Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression

Published:2015-04 Issue:4 Volume:23 Page:769-778
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Curran Kevin J,Seinstra Beatrijs A,Nikhamin Yan,Yeh Raymond,Usachenko Yelena,van Leeuwen Dayenne G,Purdon Terence,Pegram Hollie J,Brentjens Renier J

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference51 articles.

1. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions;Curran;J Gene Med,2012

2. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

3. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011

4. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N Engl J Med,2011

5. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers;Expert Opinion on Therapeutic Targets;2024-09-05

2. CAR-NK cell therapy in AML: Current treatment, challenges, and advantage;Biomedicine & Pharmacotherapy;2024-08

3. The complexities of T-cell dysfunction in chronic lymphocytic leukemia;Seminars in Hematology;2024-06

4. CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects;Journal of Clinical Medicine;2024-05-29

5. Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies;Seminars in Hematology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3